메뉴 건너뛰기




Volumn 1, Issue , 2006, Pages 53-63

Current concepts on the pathogenesis of the hypereosinophilic syndrome/chronic eosinophilic Leukemia

Author keywords

Chronic eosinophilic leukemia; FIP1L1 PDGFR ; Hypereosinophilic syndrome eosinophils; Mast cells

Indexed keywords

ALPHA INTERFERON; CHEMOATTRACTANT; CYTOKINE; G PROTEIN COUPLED RECEPTOR; HYBRID PROTEIN; HYDROXYUREA; IMATINIB; NILOTINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN FIP1L1; PROTEIN TYROSINE KINASE; STAT5 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

EID: 61949352157     PISSN: None     EISSN: 11772727     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (6)

References (79)
  • 3
    • 0036063077 scopus 로고    scopus 로고
    • Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate
    • Ault, P., Cortes, J., Koller, C., Kaled, E.S. and Kantarjian, H. 2002. Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leuk. Res., 26:881-884.
    • (2002) Leuk. Res. , vol.26 , pp. 881-884
    • Ault, P.1    Cortes, J.2    Koller, C.3    Kaled, E.S.4    Kantarjian, H.5
  • 4
    • 33745751781 scopus 로고    scopus 로고
    • A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia
    • Bacher, U., Reiter, A., Haferlach, T., Mueller, L., Schnittger, S., Kern, W. and Schoch, C. 2006. A combination of cytomorphology, cytogenetic analysis, fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction for establishing clonality in cases of persisting hypereosinophilia. Haematologica, 91:817-820.
    • (2006) Haematologica , vol.91 , pp. 817-820
    • Bacher, U.1    Reiter, A.2    Haferlach, T.3    Mueller, L.4    Schnittger, S.5    Kern, W.6    Schoch, C.7
  • 7
    • 0028069002 scopus 로고
    • The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group
    • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H., Sultan, C. and Cox, C. 1994. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br. J. Haematol., 87:746-754.
    • (1994) Br. J. Haematol. , vol.87 , pp. 746-754
    • Bennett, J.M.1    Catovsky, D.2    Daniel, M.T.3    Flandrin, G.4    Galton, D.A.5    Gralnick, H.6    Sultan, C.7    Cox, C.8
  • 8
    • 0022670147 scopus 로고
    • Acute myelomonocytic leukemia type M4 with bone marrow eosinophilia and t(5;16)(q33;q22)
    • Bhambhani, K., Inoue, S., Tyrkus, M. and Gohle, N. 1986. Acute myelomonocytic leukemia type M4 with bone marrow eosinophilia and t(5;16)(q33;q22). Cancer Genet. Cytogenet., 20:187-188.
    • (1986) Cancer Genet. Cytogenet. , vol.20 , pp. 187-188
    • Bhambhani, K.1    Inoue, S.2    Tyrkus, M.3    Gohle, N.4
  • 10
    • 0037217955 scopus 로고    scopus 로고
    • Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells
    • Buitenhuis, M., Baltus, B., Lammers, J.W., Coffer, P.J. and Koenderman, L. 2003. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. Blood, 101:134-142.
    • (2003) Blood , vol.101 , pp. 134-142
    • Buitenhuis, M.1    Baltus, B.2    Lammers, J.W.3    Coffer, P.J.4    Koenderman, L.5
  • 11
    • 0033104707 scopus 로고    scopus 로고
    • Clonality of isolated eosinophils in the hypereosinophilic syndrome
    • Chang, H.W., Leong, K.H., Koh, D.R. and Lee, S.H. 1999. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood, 93:1651-1657.
    • (1999) Blood , vol.93 , pp. 1651-1657
    • Chang, H.W.1    Leong, K.H.2    Koh, D.R.3    Lee, S.H.4
  • 12
    • 0016430025 scopus 로고
    • The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature
    • Chusid, M.J., Dale, D.C., West, B.C. and Wolff, S.M. 1975. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore), 54:1-27.
    • (1975) Medicine (Baltimore) , vol.54 , pp. 1-27
    • Chusid, M.J.1    Dale, D.C.2    West, B.C.3    Wolff, S.M.4
  • 13
    • 0027958133 scopus 로고
    • Brief report: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome
    • Cogan, E., Schandene, L., Crusiaux, A., Cochaux, P., Velu, T. and Goldman, M. 1994. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N. Engl. J. Med., 330:535-538.
    • (1994) N. Engl. J. Med. , vol.330 , pp. 535-538
    • Cogan, E.1    Schandene, L.2    Crusiaux, A.3    Cochaux, P.4    Velu, T.5    Goldman, M.6
  • 15
    • 1642324059 scopus 로고    scopus 로고
    • The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia
    • Cools, J., Quentmeier, H., Huntly, B.J., Marynen, P., Griffin, J.D., Drexler, H.G. and Gilliland, D.G. 2004. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood, 103:2802-2805.
    • (2004) Blood , vol.103 , pp. 2802-2805
    • Cools, J.1    Quentmeier, H.2    Huntly, B.J.3    Marynen, P.4    Griffin, J.D.5    Drexler, H.G.6    Gilliland, D.G.7
  • 18
    • 0030044360 scopus 로고    scopus 로고
    • Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
    • Daub, H., Weiss, F.U., Wallasch, C. and Ullrich, A. 1996. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature, 379:557-560.
    • (1996) Nature , vol.379 , pp. 557-560
    • Daub, H.1    Weiss, F.U.2    Wallasch, C.3    Ullrich, A.4
  • 19
    • 0031718359 scopus 로고    scopus 로고
    • Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family
    • de Groot, R.P., Coffer, P.J. and Koenderman, L. 1998. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family. Cell Signal, 10:619-628.
    • (1998) Cell Signal , vol.10 , pp. 619-628
    • de Groot, R.P.1    Coffer, P.J.2    Koenderman, L.3
  • 20
    • 0041466445 scopus 로고    scopus 로고
    • Specific targeted therapy of chronic myelogenous leukemia with imatinib
    • Deininger, M.W. and Druker, B.J. 2003. Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol. Rev., 55:401-423.
    • (2003) Pharmacol. Rev. , vol.55 , pp. 401-423
    • Deininger, M.W.1    Druker, B.J.2
  • 21
    • 0025036906 scopus 로고
    • Eosinophilia in transgenic mice expressing interleukin 5
    • Dent, L.A., Strath, M., Mellor, A.L. and Sanderson, C.J. 1990. Eosinophilia in transgenic mice expressing interleukin 5. J. Exp. Med., 172:1425-1431.
    • (1990) J. Exp. Med. , vol.172 , pp. 1425-1431
    • Dent, L.A.1    Strath, M.2    Mellor, A.L.3    Sanderson, C.J.4
  • 24
    • 4043141422 scopus 로고    scopus 로고
    • FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis
    • Gilliland, G., Cools, J., Stover, E.H., Wlodarska, I. and Marynen, P. 2004. FIP1L1-PDGFRalpha in hypereosinophilic syndrome and mastocytosis. Hematol. J., 5 Suppl 3:S133-137.
    • (2004) Hematol. J. , vol.5 , pp. S133-S137
    • Gilliland, G.1    Cools, J.2    Stover, E.H.3    Wlodarska, I.4    Marynen, P.5
  • 29
    • 0014299959 scopus 로고
    • The hypereosinophilic syndromes
    • Hardy, W.R. and Anderson, R.E. 1968. The hypereosinophilic syndromes. Ann. Intern. Med., 68:1220-1229.
    • (1968) Ann. Intern. Med. , vol.68 , pp. 1220-1229
    • Hardy, W.R.1    Anderson, R.E.2
  • 32
    • 0032555202 scopus 로고    scopus 로고
    • Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells
    • Herrlich, A., Daub, H., Knebel, A., Herrlich, P., Ullrich, A., Schultz, G. and Gudermann, T. 1998. Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc. Natl. Acad. Sci. U.S.A., 95:8985-8990.
    • (1998) Proc. Natl. Acad. Sci. U.S.A. , vol.95 , pp. 8985-8990
    • Herrlich, A.1    Daub, H.2    Knebel, A.3    Herrlich, P.4    Ullrich, A.5    Schultz, G.6    Gudermann, T.7
  • 33
    • 2942594298 scopus 로고    scopus 로고
    • Juxtamembrane autoinhibition in receptor tyrosine kinases
    • Hubbard, S.R. 2004. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev. Mol. Cell Biol., 5:464-471.
    • (2004) Nat. Rev. Mol. Cell Biol. , vol.5 , pp. 464-471
    • Hubbard, S.R.1
  • 35
    • 1842579577 scopus 로고    scopus 로고
    • Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome
    • Klion, A.D., Law, M.A., Noel, P., Kim, Y.J., Haverty, T.P. and Nutman, T.B. 2004a. Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood, 103:2939-2941.
    • (2004) Blood , vol.103 , pp. 2939-2941
    • Klion, A.D.1    Law, M.A.2    Noel, P.3    Kim, Y.J.4    Haverty, T.P.5    Nutman, T.B.6
  • 36
    • 0038792233 scopus 로고    scopus 로고
    • Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness
    • Klion, A.D., Noel, P., Akin, C., Law, M.A., Gilliland, D.G., Cools, J., Metcalfe, D.D. and Nutman, T.B. 2003. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood, 101:4660-4666.
    • (2003) Blood , vol.101 , pp. 4660-4666
    • Klion, A.D.1    Noel, P.2    Akin, C.3    Law, M.A.4    Gilliland, D.G.5    Cools, J.6    Metcalfe, D.D.7    Nutman, T.B.8
  • 37
    • 0942276859 scopus 로고    scopus 로고
    • Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome
    • Klion, A.D., Robyn, J., Akin, C., Noel, P., Brown, M., Law, M., Metcalfe, D.D., Dunbar, C. and Nutman, T.B. 2004b. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood, 103:473-478.
    • (2004) Blood , vol.103 , pp. 473-478
    • Klion, A.D.1    Robyn, J.2    Akin, C.3    Noel, P.4    Brown, M.5    Law, M.6    Metcalfe, D.D.7    Dunbar, C.8    Nutman, T.B.9
  • 40
    • 0021930188 scopus 로고
    • Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia
    • Le Beau, M.M., Diaz, M.O., Karin, M. and Rowley, J.D. 1985. Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia. Nature, 313:709-711.
    • (1985) Nature , vol.313 , pp. 709-711
    • Le Beau, M.M.1    Diaz, M.O.2    Karin, M.3    Rowley, J.D.4
  • 41
    • 14844288048 scopus 로고    scopus 로고
    • The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib
    • Li, B., Zhang, G.S., Dai, C.W. and Pei, M.F. 2005. [The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib]. Zhonghua Yi Xue Za Zhi, 85:448-452.
    • (2005) Zhonghua Yi Xue Za Zhi , vol.85 , pp. 448-452
    • Li, B.1    Zhang, G.S.2    Dai, C.W.3    Pei, M.F.4
  • 42
    • 0035282909 scopus 로고    scopus 로고
    • Interleukin 3 and granulocyte-macrophage colonystimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
    • Li, S., Gillessen, S., Tomasson, M.H., Dranoff, G., Gilliland, D.G. and Van Etten, R.A. 2001. Interleukin 3 and granulocyte-macrophage colonystimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood, 97:1442-1450.
    • (2001) Blood , vol.97 , pp. 1442-1450
    • Li, S.1    Gillessen, S.2    Tomasson, M.H.3    Dranoff, G.4    Gilliland, D.G.5    Van Etten, R.A.6
  • 44
    • 0029020637 scopus 로고
    • Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: A fluorescence in situ hybridization study
    • Ma, S.K., Wong, K.F., Chan, J.K. and Kwong, Y.L. 1995. Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosinophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study. Br. J. Haematol., 90:216-218.
    • (1995) Br. J. Haematol. , vol.90 , pp. 216-218
    • Ma, S.K.1    Wong, K.F.2    Chan, J.K.3    Kwong, Y.L.4
  • 48
    • 0025093035 scopus 로고
    • Hypereosinophilic syndrome with evolution to myeloproliferative disorder: Temporal relationship to loss of Y chromosome and c-N-ras activation
    • Needleman, S.W., Mane, S.M., Gutheil, J.C., Kapil, V., Heyman, M.R. and Testa, J.R. 1990. Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activation. Hematol. Pathol., 4:149-155.
    • (1990) Hematol. Pathol. , vol.4 , pp. 149-155
    • Needleman, S.W.1    Mane, S.M.2    Gutheil, J.C.3    Kapil, V.4    Heyman, M.R.5    Testa, J.R.6
  • 49
    • 33746473457 scopus 로고    scopus 로고
    • Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T674I mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy
    • Ohnishi, H., Kandabashi, K., Maeda, Y., Kawamura, M. and Watanabe, T. 2006. Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T674I mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy. Br. J. Haematol.
    • (2006) Br. J. Haematol.
    • Ohnishi, H.1    Kandabashi, K.2    Maeda, Y.3    Kawamura, M.4    Watanabe, T.5
  • 53
  • 55
    • 1342279452 scopus 로고    scopus 로고
    • Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders
    • Pardanani, A. and Tefferi, A. 2004. Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. Leuk. Res., 28 Suppl 1:S47-52.
    • (2004) Leuk. Res. , vol.28 , pp. S47-S52
    • Pardanani, A.1    Tefferi, A.2
  • 57
    • 0028932040 scopus 로고
    • Alpha-Interferon and hypereosinophilic syndrome with trisomy 8: Karyotypic remission
    • Quiquandon, I., Claisse, J.F., Capiod, J.C., Delobel, J. and Prin, L. 1995. alpha-Interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission. Blood, 85:2284-2285.
    • (1995) Blood , vol.85 , pp. 2284-2285
    • Quiquandon, I.1    Claisse, J.F.2    Capiod, J.C.3    Delobel, J.4    Prin, L.5
  • 58
    • 0023568002 scopus 로고
    • Tlymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome
    • Raghavachar, A., Fleischer, S., Frickhofen, N., Heimpel, H. and Fleischer, B. 1987. Tlymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome. J. Immunol., 139:3753-3758.
    • (1987) J. Immunol. , vol.139 , pp. 3753-3758
    • Raghavachar, A.1    Fleischer, S.2    Frickhofen, N.3    Heimpel, H.4    Fleischer, B.5
  • 62
    • 3042742422 scopus 로고    scopus 로고
    • Recent advances in pathogenesis and management of hypereosinophilic syndromes
    • Roufosse, F., Cogan, E. and Goldman, M. 2004. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy, 59:673-689.
    • (2004) Allergy , vol.59 , pp. 673-689
    • Roufosse, F.1    Cogan, E.2    Goldman, M.3
  • 63
    • 0035823530 scopus 로고    scopus 로고
    • Case report: Rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate
    • Schaller, J.L. and Burkland, G.A. 2001. Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. Med. Gen. Med., 3:9.
    • (2001) Med. Gen. Med. , vol.3 , pp. 9
    • Schaller, J.L.1    Burkland, G.A.2
  • 64
    • 21344433296 scopus 로고    scopus 로고
    • Chromosome Banding Analysis, FISH and RT-PCR Performed in Parallel in Hypereosinophilic Syndrome Establishes the Diagnosis of Chronic Eosinophilic Leukemia in 22% of Cases: A Study on 40 Patients
    • Schoch, C., Reiter, A., Bursch, S., Schnittger, S., Hiddemann, W., Kern, W. and Haferlach, T. 2004. Chromosome Banding Analysis, FISH and RT-PCR Performed in Parallel in Hypereosinophilic Syndrome Establishes the Diagnosis of Chronic Eosinophilic Leukemia in 22% of Cases: A Study on 40 Patients. Blood, 104:2444.
    • (2004) Blood , vol.104 , pp. 2444
    • Schoch, C.1    Reiter, A.2    Bursch, S.3    Schnittger, S.4    Hiddemann, W.5    Kern, W.6    Haferlach, T.7
  • 65
    • 33646152550 scopus 로고    scopus 로고
    • Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia
    • Score, J., Curtis, C., Waghorn, K., Stalder, M., Jotterand, M., Grand, F.H. and Cross, N.C. 2006. Identification of a novel imatinib responsive KIF5B-PDGFRA fusion gene following screening for PDGFRA overexpression in patients with hypereosinophilia. Leukemia, 20:827-832.
    • (2006) Leukemia , vol.20 , pp. 827-832
    • Score, J.1    Curtis, C.2    Waghorn, K.3    Stalder, M.4    Jotterand, M.5    Grand, F.H.6    Cross, N.C.7
  • 66
    • 0344809973 scopus 로고    scopus 로고
    • Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia
    • Simon, H.U., Plotz, S.G., Dummer, R. and Blaser, K. 1999. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N. Engl. J. Med., 341:1112-1120.
    • (1999) N. Engl. J. Med. , vol.341 , pp. 1112-1120
    • Simon, H.U.1    Plotz, S.G.2    Dummer, R.3    Blaser, K.4
  • 67
    • 2442697890 scopus 로고    scopus 로고
    • Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses
    • Smith, K.J., Jacobson, E., Hamza, S. and Skelton, H. 2004. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses. Arch. Dermatol., 140:584-588.
    • (2004) Arch. Dermatol. , vol.140 , pp. 584-588
    • Smith, K.J.1    Jacobson, E.2    Hamza, S.3    Skelton, H.4
  • 68
    • 0023165265 scopus 로고
    • A case of monosomy-7 eosinophilic leukemia and neurofibromatosis, terminated with disseminated cryptococcosis
    • Song, H.S. and Park, S.K. 1987. A case of monosomy-7 eosinophilic leukemia and neurofibromatosis, terminated with disseminated cryptococcosis. Korean J. Intern. Med., 2:131-134.
    • (1987) Korean J. Intern. Med. , vol.2 , pp. 131-134
    • Song, H.S.1    Park, S.K.2
  • 71
    • 0021329244 scopus 로고
    • 8;21 translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features
    • Swirsky, D.M., Li, Y.S., Matthews, J.G., Flemans, R.J., Rees, J.K. and Hayhoe, F.G. 1984. 8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features. Br. J. Haematol., 56:199-213.
    • (1984) Br. J. Haematol. , vol.56 , pp. 199-213
    • Swirsky, D.M.1    Li, Y.S.2    Matthews, J.G.3    Flemans, R.J.4    Rees, J.K.5    Hayhoe, F.G.6
  • 72
    • 3242742988 scopus 로고    scopus 로고
    • FIP1L1-PDGFRA and c-kit D816V mutationbased clonality studies in systemic mast cell disease associated with eosinophilia
    • Tefferi, A., Lasho, T.L., Brockman, S.R., Elliott, M.A., Dispenzieri, A. and Pardanani, A. 2004. FIP1L1-PDGFRA and c-kit D816V mutationbased clonality studies in systemic mast cell disease associated with eosinophilia. Haematologica, 89:871-873.
    • (2004) Haematologica , vol.89 , pp. 871-873
    • Tefferi, A.1    Lasho, T.L.2    Brockman, S.R.3    Elliott, M.A.4    Dispenzieri, A.5    Pardanani, A.6
  • 73
    • 33646245681 scopus 로고    scopus 로고
    • Eosinophilia: Secondary, clonal and idiopathic
    • Tefferi, A., Patnaik, M.M. and Pardanani, A. 2006. Eosinophilia: secondary, clonal and idiopathic. Br. J. Haematol., 133:468-492.
    • (2006) Br. J. Haematol. , vol.133 , pp. 468-492
    • Tefferi, A.1    Patnaik, M.M.2    Pardanani, A.3
  • 76
    • 33745059630 scopus 로고    scopus 로고
    • The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib)
    • author reply 4972
    • von Bubnoff, N., Gorantla, S.P., Thone, S., Peschel, C. and Duyster, J. 2006. The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib). Blood, 107:4970-4971; author reply 4972.
    • (2006) Blood , vol.107 , pp. 4970-4971
    • von Bubnoff, N.1    Gorantla, S.P.2    Thone, S.3    Peschel, C.4    Duyster, J.5
  • 77
    • 0017626122 scopus 로고
    • Ph1-negative eosinophilic leukaemia with trisomy 8. Case report and review of cytogenetic studies
    • Weinfeld, A., Westin, J. and Swolin, B. 1977. Ph1-negative eosinophilic leukaemia with trisomy 8. Case report and review of cytogenetic studies. Scand. J. Haematol. 18:413-420.
    • (1977) Scand. J. Haematol. , vol.18 , pp. 413-420
    • Weinfeld, A.1    Westin, J.2    Swolin, B.3
  • 78
    • 33646228323 scopus 로고    scopus 로고
    • The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease
    • Yamada, Y., Rothenberg, M.E., Lee, A.W., Akei, H.S., Brandt, E.B., Williams, D.A. and Cancelas, J.A. 2006. The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease. Blood, 107:4071-4079.
    • (2006) Blood , vol.107 , pp. 4071-4079
    • Yamada, Y.1    Rothenberg, M.E.2    Lee, A.W.3    Akei, H.S.4    Brandt, E.B.5    Williams, D.A.6    Cancelas, J.A.7
  • 79
    • 14844300589 scopus 로고    scopus 로고
    • Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome
    • Zhang, G.S., Li, B., Pei, M.F., Dai, C.W., Zheng, W.L. and Shen, J.K. 2004. [Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome]. Zhonghua Yi Xue Za Zhi, 84:1541-1544.
    • (2004) Zhonghua Yi Xue Za Zhi , vol.84 , pp. 1541-1544
    • Zhang, G.S.1    Li, B.2    Pei, M.F.3    Dai, C.W.4    Zheng, W.L.5    Shen, J.K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.